Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Basic and Clinical Andrology|July 4, 2024
Stem cell therapy in diabetic men with erectile dysfunction: a 24-month follow-up of safety and efficacy of two intracavernous autologous bone marrow derived mesenchymal stem cells injections, an open label phase 2 clinical trialSaddam Al Demour, Sofia Adwan, Hanan Jafar, et al.
Saudi Medical Journal|February 6, 2004
Thrombocytopenia responding to red blood cell transfusionAhmed A Mubarak, Abdalla Awidi, Kakil I Rasul, et al.
Leukemia Research|September 12, 2009
Determination of imatinib plasma levels in patients with chronic myeloid leukemia by high performance liquid chromatography-ultraviolet detection and liquid chromatography-tandem mass spectrometry: methods' comparisonAbdalla Awidi, Isam I Salem, Naji Najib, et al.
Dentistry Journal|February 13, 2020
Biocompatibility of Biodentine™ <sup>®</sup> with Periodontal Ligament Stem Cells: In Vitro StudyDuaa Abuarqoub, Nazneen Aslam, Hanan Jafar, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 28, 2022
A Descriptive Study of the Physical Direct Interaction between Adipose Tissue-Mesenchymal Stem Cells and Colo 205 Cells: Impact on Cancer Cells Stemness, and Intracellular Reactive Oxygen Species LevelsNour Sharar, Amjad A Mahasneh, Djeda Belharazem, et al.
Cell and Tissue Research|July 30, 2020
Neuro-regenerative potential of dental stem cells: a concise reviewDuaa Abuarqoub, Nazneen Aslam, Bayan Almajali, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|August 4, 2009
Primary myelodysplastic syndrome in Jordan: a single-centre experienceAbdalla Awidi, Ahmad Magableh, Ziad Taimeh, et al.
Urologia Internationalis|August 12, 2021
Safety and Efficacy of 2 Intracavernous Injections of Allogeneic Wharton's Jelly-Derived Mesenchymal Stem Cells in Diabetic Patients with Erectile Dysfunction: Phase 1/2 Clinical TrialSaddam Al Demour, Sofia Adwan, Hanan Jafar, et al.
Frontiers in Immunology|October 15, 2021
Human Wharton's Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic PatientsMairvat Al- Mrahleh, Suzan Matar, Hanan Jafar, et al.
International Journal of Molecular Sciences|December 10, 2021
Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer CellsEzaldeen Esawi, Walhan Alshaer, Ismail Sami Mahmoud, et al.
Pageof 11